Inventor profile of:

Hartmut Ehrlich

City:

Vienna

Country:

Austria

Published Applications:

28

Last publication date:

2021-09-30

Top Assignees for applications by Hartmut Ehrlich

The entities that hold a legal rights for patent applications filed by inventor Ehrlich Hartmut:

Recent patent applications by Ehrlich Hartmut

Hartmut Ehrlich from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-30
US20210300997A1
Chemistry; metallurgy

IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES

#2 | 2020-07-09
US20200216518A1
Chemistry; metallurgy

IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES

#3 | 2018-10-11
US20180291087A1
Chemistry; metallurgy

IgG stimulated remyelination of peripheral nerves

#4 | 2018-03-15
US20180072784A1
Chemistry; metallurgy

TFPI inhibitors and methods of use

#5 | 2017-09-21
US20170267743A1
Chemistry; metallurgy

FVIII PEPTIDES FOR IMMUNE TOLERANCE INDUCTION AND IMMUNODIAGNOSTICS

#6 | 2017-05-04
US20170121735A1
Chemistry; metallurgy

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

#7 | 2015-08-20
US20150232536A1
Chemistry; metallurgy

IgG stimulated remyelination of peripheral nerves

#8 | 2015-08-20
US20150232514A1
Chemistry; metallurgy

TFPI inhibitors and methods of use

#9 | 2015-07-23
US20150203567A1
Chemistry; metallurgy

FVIII peptides for immune tolerance induction and immunodiagnostics

#10 | 2014-02-20
US20140050759A1
Human necessities

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

#11 | 2013-11-14
US20130302820A1
Physics

Methods and compositions for treating bleeding disorders

#12 | 2013-10-17
US20130274193A1
Chemistry; metallurgy

TFPI inhibitors and methods of use

#13 | 2013-10-03
US20130259863A1
Chemistry; metallurgy

TFPI inhibitors and methods of use

#14 | 2013-08-29
US20130224150A1
Human necessities

IgG stimulated remyelination of peripheral nerves

#15 | 2012-12-06
US20120309021A1
Physics

DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES

#16 | 2012-05-31
US20120135019A1
Chemistry; metallurgy

FVIII peptides for immune tolerance induction and immunodiagnostics

#17 | 2012-04-05
US20120082987A1
Chemistry; metallurgy

Transgenic non-human animals expressing human blood clotting factors and uses thereof

#18 | 2012-02-02
US20120028901A1
Human necessities

TFPI inhibitors and methods of use

#19 | 2011-10-06
US20110244478A1
Physics

Methods and compositions for treating bleeding disorders

#20 | 2011-07-21
US20110177094A1
Chemistry; metallurgy

IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE

#21 | 2011-07-14
US20110172156A1
Physics

Methods and compositions for treating bleeding disorders

#22 | 2011-06-30
US20110159031A1
Human necessities

Vaccine to Influenza A Virus

#23 | 2011-03-24
US20110070592A1
Physics

Detection of antibody that binds to water soluble polymer-modified polypeptides

#24 | 2010-07-29
US20100189745A1
Human necessities

Production of viral vaccine

#25 | 2010-07-08
US20100173847A1
Chemistry; metallurgy

TFPI inhibitors and methods of use

#26 | 2009-09-17
US20090235369A1
Chemistry; metallurgy

Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof

#27 | 2009-09-03
US20090221017A1
Physics

Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro

#28 | 2009-06-11
US20090148463A1
Chemistry; metallurgy

IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease

InventorID:

413609 ⎘